Impact Events
Juniper Green Energy Incorporates Two Wholly Owned Subsidiaries
Juniper Green Energy Limited has announced the incorporation of two new wholly owned subsidiaries: Juniper Green Stellar Fifteen Private Limited and Juniper Green Beta Eight Private Limited. Both entities were incorporated on October 20, 2026, in India. These subsidiaries are established to focus on the development, establishment, and operation of renewable energy power generation projects. Juniper Green Energy Limited subscribed to 1,50,000 equity shares of face value Rs. 10 each at par in each subsidiary, totaling an investment of Rs. 30,00,000 (₹15,00,000 per subsidiary). This move signifies the company's strategic expansion within the renewable energy sector.
Indian Card Clothing Appoints Tushar Vaidya as Additional Director
Indian Card Clothing Company Ltd announced the appointment of Mr. Tushar Arvind Vaidya as an Additional Director in the category of Non-Independent Non-Executive Director. The appointment, effective October 20, 2026, is subject to shareholder approval. Mr. Vaidya brings over 35 years of experience in various industries including manufacturing, FMCG, and private equity, with prior board experience at Oman Ceramics SAOG.
SIS Ltd Completes Share Buyback
SIS Limited has announced the completion of its share buyback program. The company repurchased 25,02,674 fully paid-up equity shares of face value INR 5/- each from the open market. This buyback was conducted in accordance with SEBI (Buy-Back of Securities) Regulations, 2018, and the Companies Act, 2013. The company has published a post-buyback public advertisement on October 19, 2026, in Business Standard (English and Hindi all editions) and New India Herald (Hindi, Patna edition).
Hexaware Technologies declares interim dividend of ₹9.50
Hexaware Technologies Ltd has announced its second interim dividend of ₹9.50 per equity share (950%) for the financial year 2026. The record date for determining eligible shareholders is October 26, 2026, with the payment date set for November 07, 2026. This announcement follows a previous intimation on October 15, 2026, and the decision was made via a circular resolution by the Board of Directors on October 20, 2026. The company will also host this information on its website.
Hexaware Technologies declares interim dividend of ₹9.50 per share
Hexaware Technologies Ltd announced its second interim dividend for the financial year 2026. The Board of Directors, through a circular resolution on October 20, 2026, approved a dividend of ₹9.50 per equity share (950%). The record date for determining eligible shareholders is October 26, 2026, with the payment date set for November 07, 2026. This information will be available on the company's website.
Kirloskar Brothers Board Meeting on Oct 27, 2026
Kirloskar Brothers Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The results will be presented on both a standalone and consolidated basis.
CL Educate Director Yatrik Vin Resigns
CL Educate Limited announced the resignation of Mr. Yatrik Vin from his position as Non-Executive Independent Director. The resignation is effective immediately, as communicated by Mr. Vin via email on October 19, 2026. He cited personal and other professional commitments as the reasons for his departure. The company has complied with regulatory requirements by filing the necessary disclosures.
Shri Krishna Prasadam Ltd Board Meeting on Oct 23, 2026
Shri Krishna Prasadam Ltd has announced a Board of Directors meeting scheduled for October 23, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. The meeting will also address any other matters with the Board's permission. The company also noted that its trading is currently suspended due to procedural reasons.
Shri Krishna Prasadam Ltd Board Meeting on Oct 23, 2026
Shri Krishna Prasadam Ltd has announced a Board of Directors meeting scheduled for October 23, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. The meeting will also address any other matters with the Board's permission. The company also noted that its trading is currently suspended due to procedural reasons.
Dr Agarwals Eye Hospital Fixes Nov 18 Record Date for Amalgamation Share Swap
Dr Agarwals Eye Hospital Ltd has fixed November 18, 2026, as the record date for the allotment of consideration shares to its eligible shareholders as part of the amalgamation scheme with Dr. Agarwal's Health Care Limited. The amalgamation scheme, approved by the National Company Law Tribunal (NCLT) on September 30, 2026, will become effective from November 1, 2026. Shareholders of Dr. Agarwals Eye Hospital will receive 23 equity shares of Dr. Agarwal's Health Care for every 2 shares held. Upon the scheme becoming effective, Dr. Agarwals Eye Hospital will stand dissolved without winding up.
Dr Agarwals Eye Hospital: Amalgamation Effective Nov 1, Record Date Nov 18
Dr Agarwals Eye Hospital Ltd announced that its Scheme of Amalgamation with Dr. Agarwal's Health Care Limited will become effective from November 1, 2026. The Board of Directors fixed November 18, 2026, as the Record Date for determining eligible shareholders entitled to receive consideration shares. The share exchange ratio is 23 equity shares of Dr. Agarwal's Health Care Limited for every 2 equity shares of Dr. Agarwal's Eye Hospital Limited. Upon the scheme becoming effective, the Transferor Company (Dr. Agarwals Eye Hospital Ltd) will stand dissolved without winding up.
Aptus Pharma Board Approves Unaudited Financial Results
Aptus Pharma Ltd announced that its Board of Directors, in a meeting held on October 20, 2026, approved the unaudited standalone financial results for the half year ended September 30, 2026. The Statutory Auditors have issued a Limited Review Report on these results. Additionally, the company informed that the trading window for designated persons will open on October 23, 2026.
KS Smart Technologies to Incorporate US Subsidiary
KS Smart Technologies Ltd has announced a proposal to incorporate a foreign step-down subsidiary in the United States of America. This entity will be a wholly owned subsidiary of KS Smart Solutions Private Limited, which is itself a wholly owned subsidiary of KS Smart Technologies. The new US entity will operate in the Technology and IT sector, aligning with the parent company's business activities. The primary objective is to support international expansion, strengthen global market presence, explore new business opportunities, and enhance the ability to serve international clients. The initial investment will be a cash consideration of up to USD 510/- for 51% shareholding by KS Smart Solutions Private Limited. This move is expected to contribute to the company's long-term growth by facilitating access to global markets and improving operational efficiencies.
Home First Finance Board Meeting on Oct 27, 2026
Home First Finance Company India Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item for this meeting is to consider and approve the Reviewed Financial Results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for designated persons and their immediate relatives remains closed from October 1, 2026, until 48 hours after the declaration of these financial results.
Dr. Agarwals Health Care: Record Date Fixed for Amalgamation
Dr. Agarwals Health Care Limited announced that its Board of Directors has fixed Wednesday, November 18, 2026, as the record date for determining eligible shareholders entitled to receive consideration shares as part of the amalgamation scheme with Dr. Agarwals Eye Hospital Limited. The amalgamation scheme is set to become effective from November 1, 2026, with an appointed date of April 1, 2026. The authorized share capital of Dr. Agarwals Health Care Limited will be merged and increased. The share exchange ratio is 23 equity shares of ₹1 each of Dr. Agarwals Health Care for every 2 equity shares of ₹10 each held in Dr. Agarwals Eye Hospital.